Found 13 matching trials
A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients PHASE4 This study will assess whether a calcineurin inhibitor (CNI)-free regimen w...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients. PHASE3 Assuming greater efficacy in the prevention of acute rejection in the EVR a...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
EVR and EPO for Liver Transplant Tolerance PHASE1 This is an open label, single-arm, multicenter phase 1b study of stable adu...
Show More Location
University of California San Francisco School of Medicine
Learn More & Join Trial
Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation PHASE1 The purpose of this study is look at the safety of:
* Taking a specific co...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Twice-daily Tacrolimus and Everolimus Convert to Once-daily Tacrolimus and Everolimus in Liver Transplant Recipient PHASE4 It has been identified that nonadherence to immunosuppressant regimen may c...
Show More Location
Chang Gung Memorial Hospital
Learn More & Join Trial
Liver Transplantation With Tregs at MGH PHASE1 This is a single-center, prospective, open-label, non-randomized clinical t...
Show More Status
Active Not Recruiting
Location
Massachusetts General Hospital: Transplantation
Learn More & Join Trial
Belatacept With Early Steroid Withdrawal rATG and Everolimus in Renal Transplantation (BETTER Trial) PHASE4 This study is designed to determine the safety and efficacy of two calcineu...
Show More Location
The Christ Hospital
Learn More & Join Trial
Liver Transplantation With Tregs at UCSF PHASE1 This is a single-center, prospective, open-label, non-randomized clinical t...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation PHASE4 Patients who receive renal transplantation at Barnes Jewish Hospital (BJH) ...
Show More Location
Washington University
Learn More & Join Trial
Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant Recipients PHASE4 This trial evaluated the efficacy and safety of Everolimus in combination w...
Show More Location
Novartis Investigative Site
Learn More & Join Trial